The vagus nerve is the body’s longest cranial nerve, wandering from the brainstem down to the heart and gut, and its auricular branch provides a rare accessible entry point for external stimulation. When electrodes stimulate the cymba concha of the left ear, signals travel along afferent vagal fibers to the nucleus tractus solitarius in the brainstem, which in turn activates the locus coeruleus and basal forebrain. These nuclei trigger the release of norepinephrine and acetylcholine, two neuromodulators critical for arousal regulation, synaptic plasticity, and cognitive control. In animal models, vagus nerve stimulation has been shown to enhance cognitive flexibility and memory, and to consolidate the synaptic plasticity produced by learning itself. The Dallas team, led by F. M. Filbey, wanted to translate those preclinical findings into a controlled human model that assessed multiple domains of executive function rather than the narrow learning paradigms that have dominated most human taVNS studies to date.

Forty-two healthy volunteers aged 18 to 54 were recruited from the community and assigned to either active or sham stimulation using an alternating allocation procedure stratified by age and sex, a quasi-experimental design in which participants were blinded to their condition but assignment was not fully randomized. After completing mood questionnaires and having their heart rate variability monitored with a validated chest strap, participants received one hour of cognitive training through the BrainHQ program while wearing the NEMOS taVNS device. In the active condition, electrodes were placed on the cymba concha of the left ear, targeting the auricular vagal branch; in the sham condition, they were placed on the center of the ear lobe, which lacks vagal innervation. Stimulation intensity was individually calibrated just below each participant’s pain threshold, with pulses of 200 to 300 microseconds delivered at 25 Hz in cycles of 30 seconds on and 30 seconds off.

BrainHQ is an adaptive, computer-based training program whose algorithm continuously adjusts task difficulty based on moment-to-moment performance, ramping up challenge when participants succeed and easing off when they struggle. The participants worked through three tasks in fixed sequence: Mind Bender, a set-shifting exercise; Divided Attention, which trains discrimination of specific criteria in competing images; and Mixed Signals, a Stroop-based task matching auditory and visual stimuli. This continuously adaptive design was central to the study’s logic. Because the algorithm keeps performance near an individual’s capacity, it continuously taxes cognitive control processes rather than allowing them to plateau, potentially making the training sensitive to subtle transient changes in neural state that static tasks might miss.

After the training hour and a rest break, participants were fitted with a 64-channel EEG cap and underwent simultaneous taVNS and EEG recording during rest with eyes closed and eyes open, followed by a monetary incentive delay task measuring responses to reward and punishment. The researchers then collected a battery of executive function assessments targeting the three core components of the classic tripartite model: cognitive flexibility via the Dimensional Change Card Sort, inhibitory control via the Flanker test, and working memory via the List Sorting test, along with a modified Stroop Color Word task. Spectral power and coherence were calculated across delta, theta, alpha, beta, and gamma bands, with electrodes grouped into frontal, central, parietal, and occipital regions in each hemisphere to map how cortical communication differed between groups.

The results painted a nuanced picture. Unadjusted multivariate analyses suggested a significant overall effect of taVNS on executive function measures, and follow-up comparisons showed that the active group outperformed the sham group on BrainHQ, earning more total stars with a moderate-to-large effect size. Yet when the models were adjusted for age, sex, and education, the evidence for an independent group effect became unclear, and the BrainHQ difference did not survive Bonferroni correction. No group differences emerged on the monetary incentive delay task, the standard Stroop, or the NIH Toolbox measures. The researchers suggest that the adaptive nature of BrainHQ may have made it more sensitive to transient neural modulation, whereas the static difficulty of the other assessments, combined with a healthy sample performing near ceiling, may have lacked sufficient sensitivity to capture momentary changes in cognitive capacity.

The EEG findings were equally intriguing. During the eyes-closed resting condition, the active group showed lower delta-band clustering coefficients than the sham group in the left frontal, central, and parietal regions, with directionally similar but more uncertain effects in left occipital and right-hemisphere regions. Delta oscillations, roughly 1 to 4 Hz, are markers of lower arousal states and large-scale network synchrony, typically linked to deep sleep or low-engagement conditions. A reduction in delta connectivity during active stimulation may reflect a down-regulation of broadly synchronized low-frequency communication and a sharpening of more focal, functionally specific connectivity, consistent with the notion that vagal modulation facilitates flexible reconfiguration of large-scale brain networks. In other words, active taVNS may push the brain toward a higher state of cognitive readiness, reducing reliance on large-scale delta synchrony and enabling more targeted, efficient neural communication. None of these regional effects met the Bonferroni-adjusted significance threshold, however, and no differences appeared in theta, alpha, beta, or gamma bands, or in any band during the eyes-open condition.

Secondary analyses revealed suggestive mood effects. The active group showed an estimated reduction in depression and tension scores from pre to post stimulation compared with the sham group, and delta-band clustering coefficients in left frontal, central, parietal, and occipital regions were positively correlated with depression improvement in the active group, though neither the mood differences nor the correlations survived correction. Notably, heart rate variability showed no clear changes during or after stimulation, aligning with a meta-analysis that found no significant effect of taVNS on vagally mediated HRV. Because auricular taVNS primarily engages afferent rather than efferent vagal pathways, its cognitive effects may be mediated predominantly by central mechanisms such as locus coeruleus-noradrenergic activation without producing detectable peripheral cardiac changes, a central-peripheral dissociation that challenges the use of HRV as a reliable biomarker for these interventions.

The authors are careful to frame their findings as exploratory and hypothesis-generating. The study lacked a pre-stimulation EEG baseline, limiting interpretation to between-group differences during the later stimulation period and precluding distinction between immediate and residual effects of the preceding training session. The quasi-experimental design, modest sample size, and sensitivity of the effects to covariate specification all warrant caution. Nevertheless, the convergence of improved adaptive training performance, reduced left-hemisphere delta connectivity, and suggestive mood benefits provides mechanistic plausibility for the idea that pairing vagal stimulation with continuously adaptive cognitive demands may maximize neuromodulatory effects by repeatedly engaging task-relevant cortical networks. The observed improvements may reflect enhanced neural efficiency emerging from the interaction between vagally mediated neuromodulation and adaptive cognitive training.

What makes this study compelling is its attempt to move beyond the narrow paradigms that have limited the field, evaluating multiple dimensions of executive function while capturing network-level modulation in real time. The divergent effects on adaptive versus static cognitive performance suggest that taVNS-mediated benefits may depend critically on task demand and complexity, a distinction supported by recent literature showing that taVNS effects on cognitive flexibility emerge specifically under high task complexity. If future studies with prespecified outcomes, theoretically justified covariates, and adequate statistical power replicate these patterns, the implications could extend from cognitive enhancement in healthy adults to clinical applications, given preclinical evidence that vagus nerve stimulation facilitates extinction learning and that taVNS ameliorates memory impairment in animal models. For now, the message is one of cautious optimism: a gentle pulse to the ear may indeed tune the brain, but the evidence is still finding its frequency.

Subject of Research: Neuroscience

Article Title: A non-randomized trial of the effects of transcutaneous auricular vagus nerve stimulation on cognitive performance and resting state connectivity

Article References: Filbey, F. M., Short, C. T., Leazure, A., Nekoui, N. E., Brown, T., Kroener, S., & Liu, C. (2026). A non-randomized trial of the effects of transcutaneous auricular vagus nerve stimulation on cognitive performance and resting state connectivity. Frontiers in Human Neuroscience, 20, Article 1801066. https://doi.org/10.3389/fnhum.2026.1801066

Image Credits: AI Generated

DOI: 10.3389/fnhum.2026.1801066

Keywords: taVNS, vagus nerve stimulation, neuromodulation, executive function, EEG, delta band, BrainHQ, cognitive training, fronto-parietal network, neural efficiency, locus coeruleus, mood

The trial, led by Yuanyuan Wang, Mingshu Tao, Zhengxiu Sun, Yongao Lin and Jinling Liu of the Jiangsu Province Key Laboratory of Anesthesiology at Xuzhou Medical University, together with corresponding authors He Liu and Jun-Li Cao, enrolled 140 patients scheduled for partial hepatectomy. Participants were randomly assigned in a double-blind design to receive either active taVNS or a sham stimulation that mimicked the procedure without delivering effective neuromodulation. Because neither the patients nor the treating and assessing teams knew who received the active intervention, the design guards against the placebo effects and observer biases that have undermined many earlier studies of neuromodulation.

The logic behind the intervention rests on decades of work mapping the vagus nerve, the longest cranial nerve in the body and the main conduit of the parasympathetic nervous system. A branch of the vagus nerve reaches the skin of the outer ear, specifically the auricular concha and cymba concha, where it lies close enough to the surface to be reached by electrodes placed on the skin. Stimulating this territory sends signals into the brainstem that can ripple outward through the autonomic nervous system, dampening inflammatory cascades in distant organs. Preclinical studies had already suggested that vagus nerve stimulation can attenuate acute organ injury, including kidney damage triggered by hepatic ischemia and reperfusion, but clinical evidence in surgical patients had remained thin.

Timing was central to the trial’s design. The active group received 60-minute stimulation sessions at four carefully chosen time points: during the first clamping of the hepatic pedicle, the bundle of vessels that supplies blood to the liver and whose intermittent clamping is used to limit blood loss but inevitably starves liver tissue of oxygen; immediately after extubation in the post-anesthesia care unit; and on the first and second postoperative days, between 6:00 and 7:00 in the morning. This schedule was engineered to bracket the two principal insults to the liver during and after hepatectomy: ischemia-reperfusion injury, which occurs when clamped tissue is reperfused with oxygenated blood and floods with reactive oxygen species and inflammatory mediators, and the systemic inflammatory response that follows major surgery.

The primary outcome was the serum level of alanine aminotransferase, or ALT, an enzyme released by damaged hepatocytes and one of the most widely used biochemical markers of liver cell injury. On postoperative day 2, the median ALT level in the active taVNS group was 144.5 units per liter, compared with 224.0 units per liter in the sham group, a difference that was statistically significant with a P value of 0.002. In practical terms, patients who received the ear stimulation experienced roughly a one-third reduction in the biochemical signature of hepatocellular injury during the critical early window after surgery.

The authors are careful about what the numbers do and do not show. They describe the effect as early and transient, meaning the protection was evident in the first days after surgery but the trial was not designed to establish whether it translates into fewer serious complications, shorter hospital stays or better long-term liver function. ALT is a sensitive but imperfect proxy: it reflects hepatocyte membrane damage rather than the full clinical picture of post-hepatectomy liver failure, which involves the remaining liver’s capacity to regenerate and sustain metabolism. As a phase II study, the trial was powered to detect a signal worth pursuing, not to justify changing surgical practice on its own.

Even so, the result is notable for the field of bioelectronic medicine, which seeks to treat disease by targeting neural circuits rather than receptors with drugs. If a simple ear electrode can meaningfully blunt liver injury, the implications extend beyond hepatectomy. Liver ischemia-reperfusion injury is a feature of liver transplantation, trauma surgery and hemorrhagic shock, and postoperative liver dysfunction remains a leading cause of morbidity in patients with compromised hepatic reserve, such as those with cirrhosis or chemotherapy-associated liver injury. A therapy that is non-invasive, inexpensive, drug-free and deliverable at the bedside would be an attractive adjunct in all of these settings.

The trial was registered with the Chinese Clinical Trial Registry under identifier ChiCTR2400092005, and the study was published open access under a Creative Commons license, with a transparent peer review file and reporting summary made available alongside the paper. The authors declare no competing interests. Funding came from a broad slate of Chinese sources, including the National Key R&D Program of China, multiple grants from the National Natural Science Foundation of China, provincial programs in Jiangsu, Zhejiang and Shanghai, and institutional support from Xuzhou Medical University; the funding organizations had no role in the design, conduct, analysis or publication of the study.

Several questions remain before taVNS could enter routine perioperative care. The optimal stimulation parameters, including frequency, intensity, duration and the precise auricular targets, are still being refined across the field, and the mechanisms mediating hepatoprotection in humans, whether through anti-inflammatory vagal reflexes, modulation of the cholinergic anti-inflammatory pathway, or effects on hepatic blood flow, have not been fully dissected in patients. Larger phase III trials with hard clinical endpoints, such as post-hepatectomy liver failure, infection rates and length of intensive care stay, would be needed to confirm benefit and define which patients stand to gain the most.

For now, the study stands as a striking proof of concept: a gentle electrical whisper delivered through the skin of the ear, timed to the most dangerous moments of liver surgery, measurably reduced the biochemical footprint of organ injury. It is a vivid demonstration that the nervous system is not merely a bystander in surgical trauma but a modifiable lever in the body’s response to it, and it will likely energize a growing effort to turn vagus nerve stimulation from an experimental curiosity into a standard tool of perioperative medicine.

Subject of Research: Effect of transcutaneous auricular vagus nerve stimulation on postoperative liver injury after partial hepatectomy

Article Title: Effect of transcutaneous auricular vagus nerve stimulation on postoperative liver injury in patients undergoing partial hepatectomy: a phase II clinical randomized trial

Article References: Wang, Y., Tao, M., Sun, Z., Lin, Y., Liu, J., Xiong, X., Li, P., Ma, T., Zhou, M., Guo, X., Hang, C., Wang, M., Han, Y., Zhang, H., Zhang, S., Liu, H., & Cao, J.-L. (2026). Effect of transcutaneous auricular vagus nerve stimulation on postoperative liver injury in patients undergoing partial hepatectomy: a phase II clinical randomized trial. Nature Communications. https://doi.org/10.1038/s41467-026-77236-2

Image Credits: AI Generated

DOI: 10.1038/s41467-026-77236-2

Keywords: taVNS, vagus nerve stimulation, partial hepatectomy, liver injury, hepatocellular carcinoma, perioperative medicine, bioelectronic medicine, randomized controlled trial, alanine aminotransferase, ischemia-reperfusion injury, neuro-immune modulation, hepatoprotection

TaVNS is a non-invasive form of vagus nerve stimulation. Instead of an implanted electrode, it delivers gentle electrical pulses through the skin of the outer ear, specifically targeting the auricular branch of the vagus nerve, the only peripheral branch of this cranial nerve that reaches the body surface. From there, sensory signals travel to the nucleus tractus solitarius in the brainstem and cascade through autonomic and neuromodulatory systems, including the locus coeruleus and other arousal-related nuclei. Because the vagus nerve is a major conduit of the parasympathetic, rest-and-digest branch of the autonomic nervous system, researchers have long hypothesized that stimulating it could shift the body’s balance away from hyperarousal, the state of physiological vigilance that many insomnia researchers consider the core dysfunction of the disorder.

Most previous mechanistic studies of taVNS in insomnia have concentrated on the cortex and limbic system, examining regions such as the default mode network, the insula, and emotional regulation circuits. What has been missing, the authors argue, is attention to the hypothalamus, and in particular the lateral hypothalamus. This small, deep structure is not a passive relay; it is a master switch for arousal. It contains populations of neurons producing orexin, also known as hypocretin, the neuropeptide whose loss causes narcolepsy, as well as neurons producing melanin-concentrating hormone, which is involved in sleep regulation. The lateral hypothalamus also projects widely to cortical and subcortical networks that govern attention, reward, and autonomic tone. If taVNS genuinely works by modulating arousal systems, the lateral hypothalamus should sit at the center of the story, yet until now its role had barely been probed.

To fill that gap, the research team, led by Jingwen Zhang, Yue Zhang, Xiyong Dai, and colleagues at the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, enrolled seventy patients with chronic insomnia and randomized them to receive either real or sham taVNS. The trial was registered with the Chinese Clinical Trial Registry in April 2019 and approved by the institution’s ethics committee, and all participants gave written informed consent. Before and after the treatment period, patients underwent resting-state functional MRI scans and completed standardized clinical instruments: the Pittsburgh Sleep Quality Index, the Insomnia Severity Index, and the Self-Rating Anxiety Scale. Using the bilateral lateral hypothalamus as seed regions, the investigators computed whole-brain functional connectivity, a measure of how synchronously activity in different brain regions fluctuates over time, and compared how these connectivity patterns changed between the real and sham stimulation groups.

The clinical results were clear. Compared with sham stimulation, real taVNS produced significantly greater reductions in PSQI, ISI, and anxiety scores, indicating improvements in sleep quality, insomnia severity, and anxiety symptoms. But the neuroimaging findings are what give the study its mechanistic teeth. Real stimulation strengthened functional connectivity between the left lateral hypothalamus and two regions: the right cerebellar Crus2 and the right precuneus. At the same time, it weakened connectivity between the left lateral hypothalamus and the left insula and the left orbital frontal cortex. Each of these changes is interpretable in the context of sleep and arousal neuroscience, and together they sketch a coherent picture of how peripheral nerve stimulation might reach deep into the brain’s arousal machinery.

Consider the strengthened connections first. The precuneus is a hub of the default mode network, the set of regions most active during rest and internally directed thought, and it is intimately involved in the transition between wakefulness and sleep. Cerebellar Crus2, meanwhile, has been repeatedly implicated in sleep-disordered networks and in the regulation of autonomic function. The finding that increased connectivity between the left lateral hypothalamus and Crus2 correlated with the degree of clinical improvement, with a correlation coefficient of -0.473 and a p-value of 0.011, is particularly striking, because it links a specific circuit change to a specific symptom outcome: the more this connection strengthened, the more patients’ sleep quality scores improved. The weakened connections tell a complementary story. The insula is central to interoception, the brain’s monitoring of internal bodily states, and hyperactive insula connectivity is often interpreted as a neural signature of heightened bodily awareness and arousal in insomnia. The orbital frontal cortex participates in valuation and emotional regulation. Reducing lateral hypothalamic coupling with these regions may reflect a dialing down of the vigilance and emotional reactivity that keep insomnia sufferers lying awake.

Beyond the group-level findings, the study ventured into more speculative but potentially transformative territory: predicting treatment response before it happens. The researchers built a whole-brain, voxel-wise support vector regression model, a machine learning approach that maps patterns of brain connectivity onto a continuous outcome, in this case the change in PSQI score within the real taVNS group. To keep the model honest, they used ReliefF feature selection to identify the most informative connectivity features, trained on seventy percent of the data and tested on the remaining thirty percent, and evaluated significance with 5,000 permutation tests. The single most predictive baseline feature involved the gyrus rectus, a medial prefrontal region adjacent to the orbital surface that is connected to limbic and autonomic circuits. The model achieved a correlation of 0.662 between predicted and observed improvement in the test set, with a p-value of 0.0264 and a permutation-corrected p-value of 0.0142.

That result, if it holds up, points toward a future in which a brief pretreatment brain scan could tell clinicians which insomnia patients are likely to respond to taVNS, sparing others the time and expense of an ineffective course. The authors are careful, however, to frame this as exploratory. The sample size was modest, the prediction analysis was conducted within the real stimulation group only, and the whole-brain machine learning approach carries well-known risks of overfitting even with permutation testing. The researchers explicitly state that these findings require validation in larger, independent cohorts and do not yet support clinical application. That caution is appropriate, and it is a welcome contrast to the hype that often surrounds brain stimulation and machine learning in popular coverage.

Nevertheless, the study’s significance is hard to overstate. It is among the first to demonstrate that a non-invasive, ear-based stimulation technique can measurably alter the functional connectivity of the lateral hypothalamus in humans, and that these alterations track with symptom improvement. It reframes taVNS not as a vague relaxation technique but as a targeted intervention on defined arousal circuitry, and it offers a candidate biomarker, lateral hypothalamic-cerebellar connectivity, for tracking treatment effects. For a disorder that is usually managed with medication or cognitive behavioral therapy, the prospect of a device-based, mechanistically grounded alternative is genuinely exciting.

Much work remains. Future studies will need larger and more diverse samples, longer follow-up periods to test whether the connectivity changes and clinical benefits persist, and designs that can disentangle taVNS effects from placebo responses more finely. Researchers will also want to determine optimal stimulation parameters, since frequency, intensity, and session duration all plausibly shape which circuits are engaged. But the core message of this trial stands on its own: the path to better sleep for chronic insomniacs may run through a small patch of skin on the ear, a wandering cranial nerve, and the ancient hypothalamic machinery that decides whether the brain stays awake or lets go into sleep.

Subject of Research: Effects of transcutaneous auricular vagus nerve stimulation on lateral hypothalamic functional connectivity in chronic insomnia

Article Title: Effects of transcutaneous auricular vagus nerve stimulation on lateral hypothalamic functional connectivity in chronic insomnia: a randomized, sham-controlled fMRI study with exploratory prediction of treatment response

Article References: Zhang, J., zhang, Y., Dai, X., Mai, R., Xu, B., & Liu, B. (2026). Effects of transcutaneous auricular vagus nerve stimulation on lateral hypothalamic functional connectivity in chronic insomnia: a randomized, sham-controlled fMRI study with exploratory prediction of treatment response. BMC Psychiatry. https://doi.org/10.1186/s12888-026-08708-4

Image Credits: AI Generated

DOI: 10.1186/s12888-026-08708-4

Keywords: chronic insomnia, taVNS, vagus nerve stimulation, lateral hypothalamus, functional connectivity, fMRI, sleep-wake regulation, machine learning, support vector regression, precuneus, cerebellum, treatment response prediction